Safety and efficacy profile of ozenoxacin 1% cream in pediatric patients with impetigo

• Main Authors: Adelaide A. Hebert, MD (Author), Theodore Rosen, MD (Author), Núria Albareda López, BS (Author), Ilonka Zsolt, MD, PhD (Author), Xavier Masramon (Author)
• Format: Book
• Published: Wolters Kluwer, 2020-03-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background: Ozenoxacin is a topical antibiotic approved in the United States for treatment of impetigo in adults and children age ≥2 months. This analysis evaluated the efficacy and safety of ozenoxacin in specific pediatric age groups. Methods: Data for children aged 2 months to <18 years recrui...